WO2005030025A3 - Stimulation for treating and diagnosing conditions - Google Patents

Stimulation for treating and diagnosing conditions Download PDF

Info

Publication number
WO2005030025A3
WO2005030025A3 PCT/IL2004/000897 IL2004000897W WO2005030025A3 WO 2005030025 A3 WO2005030025 A3 WO 2005030025A3 IL 2004000897 W IL2004000897 W IL 2004000897W WO 2005030025 A3 WO2005030025 A3 WO 2005030025A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
stimulation
support element
subject
diagnosing conditions
Prior art date
Application number
PCT/IL2004/000897
Other languages
French (fr)
Other versions
WO2005030025A2 (en
Inventor
Alon Shalev
Amir Natan
Original Assignee
Brainsgate Ltd
Alon Shalev
Amir Natan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brainsgate Ltd, Alon Shalev, Amir Natan filed Critical Brainsgate Ltd
Priority to EP04770568A priority Critical patent/EP1701767A4/en
Publication of WO2005030025A2 publication Critical patent/WO2005030025A2/en
Publication of WO2005030025A3 publication Critical patent/WO2005030025A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0546—Nasal electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0548—Oral electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A61N1/37223—Circuits for electromagnetic coupling

Abstract

Apparatus for treating a subject is provided, including an elongated generally rigid support element having a length of at least 1.8 cm, and having a distal end. The apparatus also includes one or more electrodes fixed to the support element in a vicinity of the distal end thereof, and configured to be positioned in a vicinity of a site of the subject when the support element is inserted into a body of the subject, such that a portion of the support element remains outside of the body.
PCT/IL2004/000897 2003-09-26 2004-09-26 Stimulation for treating and diagnosing conditions WO2005030025A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04770568A EP1701767A4 (en) 2003-09-26 2004-09-26 Stimulation for treating and diagnosing conditions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50616503P 2003-09-26 2003-09-26
US60/506,165 2003-09-26
US10/783,113 US7117033B2 (en) 2000-05-08 2004-02-20 Stimulation for acute conditions
US10/783,113 2004-02-20

Publications (2)

Publication Number Publication Date
WO2005030025A2 WO2005030025A2 (en) 2005-04-07
WO2005030025A3 true WO2005030025A3 (en) 2005-06-23

Family

ID=34396296

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2004/000897 WO2005030025A2 (en) 2003-09-26 2004-09-26 Stimulation for treating and diagnosing conditions

Country Status (3)

Country Link
US (1) US7117033B2 (en)
EP (1) EP1701767A4 (en)
WO (1) WO2005030025A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8406869B2 (en) 2005-08-19 2013-03-26 Brainsgate, Ltd. Post-acute electrical stimulation treatment of adverse cerebrovascular events
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US9272157B2 (en) 2010-05-02 2016-03-01 Nervive, Inc. Modulating function of neural structures near the ear
US9339645B2 (en) 2010-05-02 2016-05-17 Nervive, Inc. Modulating function of the facial nerve system or related neural structures via the ear
USD826420S1 (en) 2014-04-18 2018-08-21 Oculeve, Inc. Nasal stimulator device

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US7640062B2 (en) * 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
EP1286621A4 (en) * 2000-05-08 2009-01-21 Brainsgate Ltd Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7684859B2 (en) 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
AU2003283786A1 (en) 2002-11-14 2004-06-03 Brainsgate Ltd. Surgical tools and techniques for stimulation
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
FI119008B (en) * 2004-07-22 2008-06-13 Planmeca Oy Wireless intraoral X-ray imaging
WO2007001940A2 (en) 2005-06-23 2007-01-04 Emory University Imaging agents
US7965180B2 (en) 2006-09-28 2011-06-21 Semiconductor Energy Laboratory Co., Ltd. Wireless sensor device
US20100172842A1 (en) * 2007-05-16 2010-07-08 Yeda Research And Development Co., Ltd. At The Weizmann Institute Of Science Assessment of blood-brain barrier disruption
DE102007038160B4 (en) * 2007-08-13 2013-11-21 Forschungszentrum Jülich GmbH Apparatus for stimulating the olfactory epithelium
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
US8600512B2 (en) 2007-12-26 2013-12-03 Boston Scientific Neuromodulation Corporation Methods and systems for treating seizures caused by brain stimulation
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US20100114184A1 (en) * 2008-10-07 2010-05-06 Brainsgate Ltd. Flexible tools for preparing bony canals
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
ES2540127T3 (en) 2009-01-16 2015-07-08 The Cleveland Clinic Foundation Surgical guide for a pterygopalatine fossa therapy device
US9572695B2 (en) 2009-08-24 2017-02-21 New Phase Ltd Phase-change and shape-change materials
US20110105824A1 (en) * 2009-09-22 2011-05-05 Yosef Krespi Parasympathetically induced vasodilatation method and apparatus
JP2013508119A (en) * 2009-10-26 2013-03-07 エムキネティクス， インコーポレイテッド Method and apparatus for electromagnetic stimulation of nerves, muscles and body tissues
EP2429648A1 (en) * 2010-06-30 2012-03-21 EBS Technologies GmbH An apparatus and a method for performing a safe stimulation of a person
CN103298412B (en) * 2010-10-21 2017-05-31 尤伦·帕提 Pulmonary blood pressure is measured using through chest lung doppler ultrasound
EP2640461B1 (en) 2010-11-16 2019-06-19 The Board Of Trustees Of The Leland Stanford Junior University Systems for treatment of dry eye
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US10722282B2 (en) 2011-06-14 2020-07-28 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10456185B2 (en) 2011-06-14 2019-10-29 Aerin Medical, Inc. Methods and devices to treat nasal airways
SG10201607576PA (en) 2011-06-14 2016-11-29 Aerin Medical Inc Devices for treating nasal airways
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US9415194B2 (en) 2011-06-14 2016-08-16 Aerin Medical Inc. Post nasal drip treatment
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10275680B2 (en) 2011-10-19 2019-04-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
EP2790632B1 (en) * 2011-12-16 2017-07-19 Chordate Medical AB Device for treatment of headache disorders
CN104159555B (en) * 2011-12-16 2016-04-20 考地特医疗Ab公司 For the equipment of hypothalamic stimulation
JP6175447B2 (en) * 2011-12-16 2017-08-02 コーデイト・メディカル・アクチエボラーグＣｈｏｒｄａｔｅ Ｍｅｄｉｃａｌ ＡＢ Double stimulation
US9700721B2 (en) * 2012-05-14 2017-07-11 Autonomic Technologies, Inc. Stimulation method for treatment of ocular conditions
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
AU2015203275B2 (en) * 2013-04-19 2017-04-13 Oculeve, Inc. Nasal stimulation devices and methods
WO2014172693A2 (en) 2013-04-19 2014-10-23 Oculeve, Inc. Nasal stimulation devices and methods
EP2988668B1 (en) 2013-04-24 2019-07-24 Tel HaShomer Medical Research Infrastructure and Services Ltd. Magnetic resonance maps for analyzing tissue
US10065047B2 (en) * 2013-05-20 2018-09-04 Nervive, Inc. Coordinating emergency treatment of cardiac dysfunction and non-cardiac neural dysfunction
US10603059B2 (en) 2013-09-13 2020-03-31 Aerin Medical Inc. Hyaline cartilage shaping
US9687288B2 (en) 2013-09-30 2017-06-27 Arrinex, Inc. Apparatus and methods for treating rhinitis
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9510743B2 (en) 2013-12-17 2016-12-06 Biovision Technologies, Llc Stabilized surgical device for performing a sphenopalatine ganglion block procedure
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
EP3110405B1 (en) 2014-02-25 2020-05-06 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10736500B2 (en) * 2014-04-28 2020-08-11 Universidad Del A Sabana System and method for measuring sensory response of tissue
EP3673952A1 (en) * 2014-07-25 2020-07-01 Oculeve, Inc. Stimulation patterns for treating dry eye
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
AU2015335776B2 (en) 2014-10-22 2020-09-03 Oculeve, Inc. Stimulation devices and methods for treating dry eye
WO2016065211A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Contact lens for increasing tear production
EP3209371A4 (en) 2014-10-22 2018-10-24 Oculeve, Inc. Implantable nasal stimulator systems and methods
EP3226819B1 (en) 2014-11-25 2018-10-24 New Phase Ltd. Phase-change nanoparticle
USD772406S1 (en) 2014-12-16 2016-11-22 Biovision Technologies, Llc Surgical device
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
EP3422965B1 (en) 2016-03-04 2019-12-11 Aerin Medical, Inc. Device for eustachian tube modification
DK3238616T3 (en) * 2016-04-26 2019-04-01 Oticon As HEARING DEVICE CONTAINING ELECTRODES TO COLLECT A PHYSIOLOGICAL REACTION
CA3022683A1 (en) 2016-05-02 2017-11-09 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US11426577B2 (en) * 2016-08-26 2022-08-30 Wisconsin Alumni Research Foundation Neuromodulation to modulate glymphatic clearance
EP3525735A4 (en) * 2016-10-14 2020-03-11 Olympic Ophthalmics, Inc. Therapeutic ultrasound for eye disorders
EP3329962B1 (en) 2016-11-15 2020-05-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
RU2019118600A (en) 2016-12-02 2021-01-11 Окулив, Инк. APPARATUS AND METHOD FOR MAKING DRY EYE SYNDROME PREDICTION AND TREATMENT RECOMMENDATIONS
US11116566B2 (en) 2016-12-22 2021-09-14 Aerin Medical, Inc. Soft palate treatment
US11806071B2 (en) 2016-12-22 2023-11-07 Aerin Medical Inc. Soft palate treatment
CN106730346B (en) * 2017-01-23 2018-07-13 董希婢 Acupuncture robot and intelligent acupuncture and moxibustion system
US11278356B2 (en) 2017-04-28 2022-03-22 Arrinex, Inc. Systems and methods for locating blood vessels in the treatment of rhinitis
USD880694S1 (en) 2017-05-01 2020-04-07 Aerin Medical, Inc. Nasal airway medical instrument
US11096738B2 (en) 2017-05-05 2021-08-24 Aerin Medical, Inc. Treatment of spinal tissue
CN110612057B (en) * 2017-06-07 2022-05-31 柯惠有限合伙公司 System and method for detecting stroke
US11147735B2 (en) 2018-02-26 2021-10-19 Olympic Ophthalmics, Inc. Therapeutic handheld devices for disorders
WO2020005910A1 (en) 2018-06-28 2020-01-02 Sandler Scientific, Llc Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
USD881904S1 (en) 2018-10-31 2020-04-21 Aerin Medical Inc. Display screen with animated graphical user interface
USD902412S1 (en) 2018-10-31 2020-11-17 Aerin Medical, Inc. Electrosurgery console
JP2020089723A (en) * 2018-12-07 2020-06-11 アヴェント インコーポレイテッド Device and method for selectively and reversibly modulating nervous system structure to inhibit perception of pain
US11198002B2 (en) * 2020-01-24 2021-12-14 Medtronic Xomed, Inc. Needle and introducer used in lead placement for obstructive sleep apnea treatment
US20230200637A1 (en) * 2021-12-29 2023-06-29 Dorna Hakimimehr Devices and methods for endoscopic neuroablation in the tympanic cavity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322494B1 (en) * 1998-04-03 2001-11-27 Gyrus Medical Limited Endoscope
US20050054939A1 (en) * 2002-01-15 2005-03-10 Orsan Medical Equipment Ltd. Device for monitoring blood flow to brain

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025807A (en) * 1983-09-14 1991-06-25 Jacob Zabara Neurocybernetic prosthesis
US4907602A (en) * 1985-10-18 1990-03-13 The Mount Sinai School Of Medicine Of The City Of New York Device for controlling the glottic opening
US5639853A (en) * 1987-09-29 1997-06-17 Praxis Biologics, Inc. Respiratory syncytial virus vaccines
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
US4979511A (en) 1989-11-03 1990-12-25 Cyberonics, Inc. Strain relief tether for implantable electrode
US5154172A (en) * 1989-11-13 1992-10-13 Cyberonics, Inc. Constant current sources with programmable voltage source
US5179950A (en) * 1989-11-13 1993-01-19 Cyberonics, Inc. Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not providing stimulation
US5186170A (en) * 1989-11-13 1993-02-16 Cyberonics, Inc. Simultaneous radio frequency and magnetic field microprocessor reset circuit
US5235980A (en) * 1989-11-13 1993-08-17 Cyberonics, Inc. Implanted apparatus disabling switching regulator operation to allow radio frequency signal reception
US5188104A (en) * 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5263480A (en) 1991-02-01 1993-11-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5269303A (en) 1991-02-22 1993-12-14 Cyberonics, Inc. Treatment of dementia by nerve stimulation
US5251634A (en) 1991-05-03 1993-10-12 Cyberonics, Inc. Helical nerve electrode
US5215086A (en) * 1991-05-03 1993-06-01 Cyberonics, Inc. Therapeutic treatment of migraine symptoms by stimulation
US5299569A (en) * 1991-05-03 1994-04-05 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US5335657A (en) * 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
FR2677362B1 (en) * 1991-06-04 1995-04-28 Centre Nat Rech Scient NEUROPEPTIDES OF THE TACHYKININ FAMILY.
US5205285A (en) * 1991-06-14 1993-04-27 Cyberonics, Inc. Voice suppression of vagal stimulation
US5222494A (en) * 1991-07-31 1993-06-29 Cyberonics, Inc. Implantable tissue stimulator output stabilization system
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5215089A (en) * 1991-10-21 1993-06-01 Cyberonics, Inc. Electrode assembly for nerve stimulation
US5304206A (en) * 1991-11-18 1994-04-19 Cyberonics, Inc. Activation techniques for implantable medical device
US5237991A (en) * 1991-11-19 1993-08-24 Cyberonics, Inc. Implantable medical device with dummy load for pre-implant testing in sterile package and facilitating electrical lead connection
US5756071A (en) * 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
US5330515A (en) * 1992-06-17 1994-07-19 Cyberonics, Inc. Treatment of pain by vagal afferent stimulation
US5531778A (en) * 1994-09-20 1996-07-02 Cyberonics, Inc. Circumneural electrode assembly
US6086525A (en) * 1994-11-28 2000-07-11 Neotonus, Inc. Magnetic nerve stimulator for exciting peripheral nerves
US5725471A (en) * 1994-11-28 1998-03-10 Neotonus, Inc. Magnetic nerve stimulator for exciting peripheral nerves
US5571150A (en) 1994-12-19 1996-11-05 Cyberonics, Inc. Treatment of patients in coma by nerve stimulation
US5540730A (en) * 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US5707400A (en) * 1995-09-19 1998-01-13 Cyberonics, Inc. Treating refractory hypertension by nerve stimulation
US20020169485A1 (en) 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US6480743B1 (en) 2000-04-05 2002-11-12 Neuropace, Inc. System and method for adaptive brain stimulation
US5792067A (en) 1995-11-21 1998-08-11 Karell; Manuel L. Apparatus and method for mitigating sleep and other disorders through electromuscular stimulation
US5752515A (en) * 1996-08-21 1998-05-19 Brigham & Women's Hospital Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier
US6325475B1 (en) 1996-09-06 2001-12-04 Microfab Technologies Inc. Devices for presenting airborne materials to the nose
US7452538B2 (en) * 1997-01-28 2008-11-18 Human Genome Sciences, Inc. Death domain containing receptor 4 antibodies and methods
US20040136951A1 (en) * 1997-03-17 2004-07-15 Human Genome Sciences, Inc. Death domain containing receptor 5
US7799337B2 (en) * 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US20010004644A1 (en) * 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US6432986B2 (en) * 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US6354299B1 (en) * 1997-10-27 2002-03-12 Neuropace, Inc. Implantable device for patient communication
US6016449A (en) * 1997-10-27 2000-01-18 Neuropace, Inc. System for treatment of neurological disorders
US6230049B1 (en) * 1999-08-13 2001-05-08 Neuro Pace, Inc. Integrated system for EEG monitoring and electrical stimulation with a multiplicity of electrodes
US6459936B2 (en) 1997-10-27 2002-10-01 Neuropace, Inc. Methods for responsively treating neurological disorders
US6597954B1 (en) * 1997-10-27 2003-07-22 Neuropace, Inc. System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes
US6427086B1 (en) * 1997-10-27 2002-07-30 Neuropace, Inc. Means and method for the intracranial placement of a neurostimulator
US6647296B2 (en) 1997-10-27 2003-11-11 Neuropace, Inc. Implantable apparatus for treating neurological disorders
US5938689A (en) * 1998-05-01 1999-08-17 Neuropace, Inc. Electrode configuration for a brain neuropacemaker
US6006124A (en) 1998-05-01 1999-12-21 Neuropace, Inc. Means and method for the placement of brain electrodes
US5928272A (en) * 1998-05-02 1999-07-27 Cyberonics, Inc. Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity
US6941171B2 (en) * 1998-07-06 2005-09-06 Advanced Bionics Corporation Implantable stimulator methods for treatment of incontinence and pain
US6232326B1 (en) * 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US6531454B1 (en) * 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
US6338715B1 (en) * 1999-03-31 2002-01-15 Microfab Technologies, Inc. Digital olfactometer and method for testing olfactory thresholds
US6161045A (en) 1999-06-01 2000-12-12 Neuropace, Inc. Method for determining stimulation parameters for the treatment of epileptic seizures
US6587719B1 (en) * 1999-07-01 2003-07-01 Cyberonics, Inc. Treatment of obesity by bilateral vagus nerve stimulation
US6473644B1 (en) 1999-10-13 2002-10-29 Cyberonics, Inc. Method to enhance cardiac capillary growth in heart failure patients
US6811788B2 (en) * 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US7927612B2 (en) * 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
US6277841B1 (en) * 2000-03-02 2001-08-21 Mallinckrodt Inc. Quinoline ligands and metal complexes for diagnosis and therapy
US6473639B1 (en) 2000-03-02 2002-10-29 Neuropace, Inc. Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures
US20020026652A1 (en) * 2000-03-22 2002-02-28 Allen Keith D. Transgenic mice containing cGMP phosphodiesterase gene disruptions
US6466822B1 (en) * 2000-04-05 2002-10-15 Neuropace, Inc. Multimodal neurostimulator and process of using it
US6353754B1 (en) * 2000-04-24 2002-03-05 Neuropace, Inc. System for the creation of patient specific templates for epileptiform activity detection
EP1286621A4 (en) * 2000-05-08 2009-01-21 Brainsgate Ltd Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US6526318B1 (en) * 2000-06-16 2003-02-25 Mehdi M. Ansarinia Stimulation method for the sphenopalatine ganglia, sphenopalatine nerve, or vidian nerve for treatment of medical conditions
US20020169307A1 (en) 2000-06-21 2002-11-14 Robert Klein Transgenic mice containing LPR5 gene disruptions
US6591138B1 (en) * 2000-08-31 2003-07-08 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US6405079B1 (en) * 2000-09-22 2002-06-11 Mehdi M. Ansarinia Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions
WO2002042735A2 (en) * 2000-10-30 2002-05-30 Vanderbuilt University Human kcr1 regulation of herg potassium channel block
US6529774B1 (en) * 2000-11-09 2003-03-04 Neuropace, Inc. Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
US6591137B1 (en) * 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
IT1320847B1 (en) * 2000-11-28 2003-12-10 Bottero Spa METHOD AND MACHINE FOR THE GRINDING OF COATED GLASS SHEETS.
US6618623B1 (en) * 2000-11-28 2003-09-09 Neuropace, Inc. Ferrule for cranial implant
US20030106083A1 (en) * 2000-12-06 2003-06-05 Allen Keith D. Transgenic mice containing RPTPB tyrosine phosphatase gene disruptions
CA2436713A1 (en) * 2000-12-08 2002-08-22 Curagen Corporation Proteins and nucleic acids encoding same
US20020133841A1 (en) * 2000-12-11 2002-09-19 Leviten Michael W. Transgenic mice containing huntingtin interacting protein gene disruptions
US6609025B2 (en) * 2001-01-02 2003-08-19 Cyberonics, Inc. Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
US6597953B2 (en) * 2001-02-20 2003-07-22 Neuropace, Inc. Furcated sensing and stimulation lead
US20030018988A1 (en) * 2001-03-29 2003-01-23 Allen Keith D. Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions
US20030005473A1 (en) * 2001-03-29 2003-01-02 Brennan Thomas J. OGR1 gene disruptions, compositions and methods relating thereto
US20030018989A1 (en) * 2001-03-29 2003-01-23 Brennan Thomas J. Transgenic mice containing GPCR5-1 gene disruptions
US20030005477A1 (en) * 2001-03-29 2003-01-02 Leviten Michael W. Transgenic mice containing beta3GalT2 gene disruptions
US20030014772A1 (en) * 2001-03-29 2003-01-16 Allen Keith D. Transgenic mice containing MSK2 serine/threonine kinase gene disruptions
US7087008B2 (en) * 2001-05-04 2006-08-08 Board Of Regents, The University Of Texas System Apparatus and methods for delivery of transcranial magnetic stimulation
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
US20030166099A1 (en) * 2001-06-05 2003-09-04 Sabbadini Roger A. Minicells comprising membrane proteins
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7030291B2 (en) * 2001-06-26 2006-04-18 Deltagen, Inc. CYT28 serpentine receptor disruptions, compositions and methods relating thereto
US20030056238A1 (en) * 2001-06-26 2003-03-20 Wisotzkey Robert G. GABA B1A receptor disruptions, compositions and methods relating thereto
US20030177514A1 (en) * 2001-06-26 2003-09-18 Leviten Michael W. UBE2G2 ubiquitin-conjugating enzyme gene disruptions, compositions and methods related thereto
US6810285B2 (en) 2001-06-28 2004-10-26 Neuropace, Inc. Seizure sensing and detection using an implantable device
US6606521B2 (en) * 2001-07-09 2003-08-12 Neuropace, Inc. Implantable medical lead
US6622047B2 (en) * 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation
US6622038B2 (en) * 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of movement disorders by near-diaphragmatic nerve stimulation
US20050020519A1 (en) * 2001-08-02 2005-01-27 Albiston Anthony L. Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
US6622041B2 (en) * 2001-08-21 2003-09-16 Cyberonics, Inc. Treatment of congestive heart failure and autonomic cardiovascular drive disorders
US6662035B2 (en) 2001-09-13 2003-12-09 Neuropace, Inc. Implantable lead connector assembly for implantable devices and methods of using it
US20030172390A1 (en) * 2001-09-24 2003-09-11 Wisotzkey Robert G. Mo54 gene disruptions, compositions and methods related thereto
US20030131367A1 (en) * 2001-09-24 2003-07-10 Catherine Guenther Kv3.3b potassium channel disruptions, compositions and methods related thereto
WO2003026559A2 (en) * 2001-09-28 2003-04-03 Kurve Technology, Inc Nasal nebulizer
US7136695B2 (en) * 2001-10-12 2006-11-14 Pless Benjamin D Patient-specific template development for neurological event detection
US20030144711A1 (en) * 2002-01-29 2003-07-31 Neuropace, Inc. Systems and methods for interacting with an implantable medical device
US7110820B2 (en) * 2002-02-05 2006-09-19 Tcheng Thomas K Responsive electrical stimulation for movement disorders
AU2003241131A1 (en) * 2002-06-14 2003-12-31 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US7277748B2 (en) * 2002-09-13 2007-10-02 Neuropace, Inc. Spatiotemporal pattern recognition for neurological event detection and prediction in an implantable device
US20050074506A1 (en) * 2003-10-02 2005-04-07 Brainsgate Ltd. Targeted release of nitric oxide in the CNS circulation for modulating the BBB and treating disorders
US20050137646A1 (en) * 2003-12-22 2005-06-23 Scimed Life Systems, Inc. Method of intravascularly delivering stimulation leads into brain
US8060207B2 (en) * 2003-12-22 2011-11-15 Boston Scientific Scimed, Inc. Method of intravascularly delivering stimulation leads into direct contact with tissue

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322494B1 (en) * 1998-04-03 2001-11-27 Gyrus Medical Limited Endoscope
US20050054939A1 (en) * 2002-01-15 2005-03-10 Orsan Medical Equipment Ltd. Device for monitoring blood flow to brain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1701767A4 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8406869B2 (en) 2005-08-19 2013-03-26 Brainsgate, Ltd. Post-acute electrical stimulation treatment of adverse cerebrovascular events
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9272157B2 (en) 2010-05-02 2016-03-01 Nervive, Inc. Modulating function of neural structures near the ear
US9339645B2 (en) 2010-05-02 2016-05-17 Nervive, Inc. Modulating function of the facial nerve system or related neural structures via the ear
USD826420S1 (en) 2014-04-18 2018-08-21 Oculeve, Inc. Nasal stimulator device

Also Published As

Publication number Publication date
US20040220644A1 (en) 2004-11-04
EP1701767A2 (en) 2006-09-20
EP1701767A4 (en) 2009-12-09
US7117033B2 (en) 2006-10-03
WO2005030025A2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
WO2005030025A3 (en) Stimulation for treating and diagnosing conditions
WO2004002288A3 (en) Methods and apparatus for lead placement on a surface of the heart
WO2003105667A3 (en) Method and apparatus for tissue connection
WO2001078825A3 (en) Steerable device for introducing diagnostic and therapeutic apparatus into the body
AU2003243628A8 (en) Helical device and method for aiding the ablation and assessment of tissue
WO2001037723A3 (en) Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
EP1510180A3 (en) Steerable loop structure
WO2004012809A8 (en) A method and system for inserting an electrode
ATE516838T1 (en) MEDICAL DEVICE WITH THRUST LIMITATION
WO2006138409A3 (en) Apparatus and methods for endoluminal advancement
WO2004071279A3 (en) Surgical drain with sensors for tissue monitoring
DE69920896D1 (en) MEDICAL DEVICE THAT ENABLES ACCESS TO THE BODY
WO2002085188A3 (en) Deflectable implantation device and method for use
AU2001268963A1 (en) Apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
GB2441489A (en) Stylet apparatuses and methods of manufacture
HUP0102536A3 (en) Device and method for resecting body tissues
DE60131775D1 (en) AN IMPLANTABLE OR INTRODUCABLE DEVICE FOR DELIVERING THERAPEUTIC AGENTS
AU2002234021A1 (en) Method and device for the treatment of vulnerable tissue site
EE200000366A (en) Apparatus and method for treating body tissues with electricity or drugs
NO20025616L (en) Method and apparatus for infusing fluids into a human or animal body
WO2002009575A3 (en) Method for controlling the pain from injections or minor surgical procedures and apparatus for use therewith
CA2467004A1 (en) Tissue fixation device
AU2003239474A1 (en) Device and method for the treatment of cardiac disorders
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REEP Request for entry into the european phase

Ref document number: 2004770568

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004770568

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004770568

Country of ref document: EP